Binding to its receptors, such as CXCR2, which is expressed in neutrophils, monocytes, eosinophils, endothelial cells and others [88], CXCL5 participates in immune cell recruitment, promotes angiogenesis and is involved in tumor progression [187]. Here, CXCL5 is linked to neoplasm.